SCHEMBL12269422

SCHEMBL12269422

Cc1ccc(N(c2ccc(C)cc2)c2ccc(-c3ccc(N(c4ccc(OCC(O)CO)cc4)c4ccc(OCC(O)CO)cc4)cc3)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.49
▸ USP2 O75604 1/20 0.49
▸ AR P10275 1/20 0.46
▸ POLB P06746 2/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.45
▸ HPGD P15428 1/20 0.45
▸ KDM4E B2RXH2 2/20 0.44
▸ CYP1A2 P05177 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ RECQL P46063 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14173956 1.00 TSHR (0.49) TSHRUSP2ARPOLBSMN1; SMN2
SCHEMBL14173758 1.00 TSHR (0.49) TSHRUSP2ARPOLBSMN1; SMN2
SCHEMBL12269423 1.00 TSHR (0.49) TSHRUSP2ARPOLBSMN1; SMN2
SCHEMBL12795506 1.00 TSHR (0.49) TSHRUSP2ARPOLBSMN1; SMN2
SCHEMBL14173766 1.00 TSHR (0.49) TSHRUSP2ARPOLBSMN1; SMN2
SCHEMBL14174230 1.00 TSHR (0.49) TSHRUSP2ARPOLBSMN1; SMN2
SCHEMBL14173722 0.95 TSHR (0.53) TSHRUSP2ARPOLBSMN1; SMN2
SCHEMBL14173941 0.95 TSHR (0.53) TSHRUSP2ARPOLBSMN1; SMN2
SCHEMBL14173823 0.95 MAPT (0.46) TSHRUSP2ARPOLBALDH1A1
SCHEMBL14174110 0.95 MAPT (0.46) TSHRUSP2ARPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8017807-B2 Tetrahydroxy compound, method for preparing the tetrahydroxy compound, and photoreceptor using the tetrahydroxy compound RICOH COMPANY LIMITED (JP) 2011-09-13 — — US disclosed
US-20070128530-A1 TETRAHYDROXY COMPOUND, METHOD FOR PREPARING THE TETRAHYDROXY COMPOUND, AND PHOTORECEPTOR USING THE TETRAHYDROXY COMPOUND RICOH COMPANY, LTD. (JP) 2007-06-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070128530-A1 TETRAHYDROXY COMPOUND, METHOD FOR PREPARING THE TETRAHYDROXY COMPOUND, AND PHOTORECEPTOR USING THE TETRAHYDROXY COMPOUND ALDH1A2, SLC9B2, SLC18A2 TSHR 3057/4885USP2 4603/4885AR 3376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback